A Iolascon Selected Research

A Iolascon Research Topics

Disease

4	Neoplasms (Cancer) 04/2016 - 03/2000
4	Hereditary Spherocytosis 06/2015 - 01/2000
3	Neuroblastoma 05/2009 - 01/2000
2	Hyperbilirubinemia 08/2007 - 04/2000
2	Leukemia 03/2001 - 12/2000
1	Hereditary Elliptocytosis 06/2015
1	Chronic Hepatitis C 04/2008
1	Infections 04/2008
1	Breast Neoplasms (Breast Cancer) 03/2008
1	Hypochromic Anemia (Chlorosis) 01/2008
1	Iron Overload 01/2008
1	Embryonal Rhabdomyosarcoma 11/2002
1	Rhabdomyosarcoma 11/2002
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 03/2001
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2001
1	Thrombosis (Thrombus) 01/2001
1	Wounds and Injuries (Trauma) 01/2001
1	Activated Protein C Resistance (APC Resistance) 01/2001
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2000
1	Osteoporosis 11/2000
1	Congenital Abnormalities (Deformity) 11/2000
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2000
1	Hemolytic Anemia 10/2000
1	hereditary Xerocytosis 10/2000
1	type 2 Crigler Najjar syndrome 09/2000
1	Thrombocytopenia (Thrombopenia) 06/2000
1	Congenital Dyserythropoietic Anemia (Dyserythropoietic Anemia, Congenital) 04/2000
1	Osteoporotic Fractures 04/2000
1	Gallstones (Gallstone) 04/2000

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 09/2010 - 01/2000
3	Membrane Proteins (Integral Membrane Proteins)IBA 06/2015 - 01/2000
3	BilirubinIBA 08/2007 - 04/2000
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2000 - 03/2000
1	AntigensIBA 04/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2009
1	LigandsIBA 05/2009
1	Galectin 1 (LGALS1)IBA 05/2009
1	Antiviral Agents (Antivirals)IBA 04/2008
1	Casein Kinase I (Casein Kinase 1)IBA 03/2008
1	Serine (L-Serine)FDA Link 03/2008
1	3',5'-Cyclic-AMP Phosphodiesterases (3',5' Cyclic Nucleotide Phosphodiesterase)IBA 03/2008
1	IC 261IBA 03/2008
1	Peptides (Polypeptides)IBA 03/2008
1	Casein Kinase IdeltaIBA 03/2008
1	IronIBA 01/2008
1	Ferritins (Ferritin)IBA 01/2008
1	Transferrin (beta 2 Transferrin)IBA 01/2008
1	Phenobarbital (Luminal)FDA Link 08/2007
1	Butyrates (Butyrate)IBA 11/2002
1	Messenger RNA (mRNA)IBA 11/2002
1	von Willebrand FactorIBA 03/2001
1	von Willebrand factor receptor (VWF receptor)IBA 03/2001
1	SpectrinIBA 03/2001
1	fludarabineIBA 01/2001
1	factor V LeidenIBA 01/2001
1	Antithrombin IIIIBA 01/2001
1	Busulfan (Busulfex)FDA Link 01/2001
1	Methotrexate (Mexate)FDA LinkGeneric 01/2001
1	Oxidoreductases (Dehydrogenase)IBA 01/2001
1	PlasminogenIBA 01/2001
1	Protein CIBA 01/2001
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2001
1	Protein SIBA 01/2001
1	Integrin beta3 (GPIIIa)IBA 01/2001
1	Thrombin FDA Link 12/2000
1	CationsIBA 10/2000
1	UridineIBA 09/2000
1	Thrombopoietin ReceptorsIBA 06/2000
1	TransferasesIBA 04/2000
1	Uridine Diphosphate (UDP)IBA 04/2000
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2000
1	betaglycan (TGFBR3)IBA 03/2000
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 03/2000
1	Cyclin-Dependent Kinase 2IBA 01/2000
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2000
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2000
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2000
1	Erythropoietin FDA Link 01/2000

Therapy/Procedure

3	Therapeutics 05/2009 - 01/2000
2	Blood Transfusion (Blood Transfusions) 11/2000 - 01/2000
1	Liver Transplantation 08/2007
1	Catheters 01/2001
1	Drug Therapy (Chemotherapy) 01/2000